Skip to main content

Canaan Partners — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

269
Companies
$8.1B
Total invested
$39.5M
Avg. check
49
Industries
Biotechnology 9Artificial Intelligence (AI) 7Software 5Health Care 5Medical 4Therapeutics 4+43 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145–168 of 269
Countable
October 2021

Countable is an enterprise platform that provides tools for community and engagement.

Enterprise · San Francisco$12.0M Series A
Glooko
October 2024

Glooko provides digital health platforms and data management tools for diabetes care.

Diabetes · Palo Alto$100.0M Series F
Vima Therapeutics
March 2026

Vima Therapeutics operates as a biotechnology company.

Biotechnology · Cambridge$40.0M Series A
Transposon Therapeutics
March 2026

Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.

Biotechnology · Westport$22.0M Grant
Rapidata
February 2026

Rapidata is a data processing platform that offers human-verified innovative datalabeling and data processing services at scale.

Cloud Data Services · Zürich$8.5M Seed
Arbe
January 2026

Arbe Robotics offers real time 4D imaging radar software for autonomous driving.

Artificial Intelligence (AI) · Tel Aviv-yafo$18.5M Post Ipo Equity
Artie
January 2026

Artie is a technology platform that provides real-time data replication and streaming services to synchronize data across systems.

Analytics · San Francisco$12.0M Series A
Nocion Therapeutics
January 2026

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Biotechnology · Cambridge$23.0M Series B
HeyMilo
January 2026

HeyMilo is an AI-powered candidate screening platform that enables organizations to screen, interview, and evaluate candidates.

Artificial Intelligence (AI) · New York$3.9M Seed
Safire Technology Group
December 2025

Safire Technology Group manufactures Liquid-to-Solid, Hybrid-State Batteries.

Battery · Washington$2.7M Series Unknown
Novee Security
December 2025

Novee is an AI penetration testing platform designed to protect dynamic environments from machine-speed attackers.

Tel Aviv$10.0M Debt Financing
Quarry Thera
November 2025

Quarry Thera, a next-generation brachytherapy innovator, is advancing brachytherapy using molecular-glue technology.

Biotechnology · New Haven$32.0M Series A
Sumble
October 2025

Sumble provides a sales intelligence platform that crawls the web for technographic and contact data.

Apps · San Francisco$30.0M Series A
Doorstep AI
September 2025

Doorstep AI is an artificial intelligence company that provides centimeter precise delivery drop-off location accuracy.

Artificial Intelligence (AI) · New York$8.0M Seed
Semnur Pharmaceuticals
September 2025

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Biotechnology · Los Altos$100.0M Post Ipo Equity
Arvinas
August 2025

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Biotechnology · New HavenPost Ipo Equity
Alkymi
August 2025

Alkymi is the first end-to-end solution for turning your private markets data into actionable insights.

Analytics · New YorkSeries Unknown
Omnichent
August 2025

Omnichent is an AI-powered customer lifecycle management platform.

San Francisco$1.8M Seed
Iterum Therapeutics
August 2025

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Medical · Dublin$2.2M Post Ipo Equity
Draig Therapeutics
June 2025

Draig Therapeutics is a clinical-stage biopharmaceutical startup.

Biopharma · Cardiff$140.0M Series A
Actio Biosciences
June 2025

Actio Biosciences is a research center that develops drugs for rare diseases.

Bioinformatics · San Diego$66.0M Series B
Fireflies.ai
June 2025

Fireflies.ai is an AI‑powered meeting assistant that records, transcribes, summarizes, and analyzes meetings and conversations.

Artificial Intelligence (AI) · San FranciscoSecondary Market
Cynomi
April 2025

Cynomi provides an AI platform for automating risk assessments and compliance.

Artificial Intelligence (AI) · Herzliya$37.0M Series B
ThirtyFiveBio
April 2025

ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis

Biotechnology · AbingdonSeries Unknown

Where Canaan Partners invests

Biotechnology9
Artificial Intelligence (AI)7
Software5
Health Care5
Medical4
Therapeutics4

About Canaan Partners's portfolio

How many companies has Canaan Partners invested in?▸

Canaan Partners has invested in 269 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Canaan Partners invest in?▸

Canaan Partners's top investment sectors include Biotechnology, Artificial Intelligence (AI), Software, Health Care, Medical. The firm invests across 49 different industry categories.

What is Canaan Partners's largest investment?▸

Among tracked funding rounds, Draig Therapeutics received $140.0M in a Series A round. Canaan Partners's total known invested capital is $8.1B.

What is the average investment size for Canaan Partners?▸

Canaan Partners's average investment size is $39.5M across its portfolio of 269 companies.

What are Canaan Partners's most recent investments?▸

Recent Canaan Partners portfolio additions include Countable, Glooko, Vima Therapeutics, Transposon Therapeutics, Rapidata. These companies were founded in 2020 or later.

Reach the founders behind these 269 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →